2021
DOI: 10.1016/j.jradnu.2020.07.007
|View full text |Cite
|
Sign up to set email alerts
|

Uterine Artery Embolization: Background Review, Patient Management, and Endovascular Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(7 citation statements)
references
References 15 publications
0
7
0
Order By: Relevance
“…The prevalence of uterine leiomyomas varies between 25% and 80%, being one of the most common benign pelvic tumors in women, which develop between menarche and menopause [ 6 , 7 ]. Although many of the patients are asymptomatic, approximately 25% of them suffer from menorrhagia and secondary iron deficiency anemia, dysmenorrhea, fertility issues, urinary frequency and constipation [ 6 , 8 ]. Submucosal leiomyomas are most associated with vaginal hemorrhage [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…The prevalence of uterine leiomyomas varies between 25% and 80%, being one of the most common benign pelvic tumors in women, which develop between menarche and menopause [ 6 , 7 ]. Although many of the patients are asymptomatic, approximately 25% of them suffer from menorrhagia and secondary iron deficiency anemia, dysmenorrhea, fertility issues, urinary frequency and constipation [ 6 , 8 ]. Submucosal leiomyomas are most associated with vaginal hemorrhage [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Although many of the patients are asymptomatic, approximately 25% of them suffer from menorrhagia and secondary iron deficiency anemia, dysmenorrhea, fertility issues, urinary frequency and constipation [ 6 , 8 ]. Submucosal leiomyomas are most associated with vaginal hemorrhage [ 6 ]. Besides the fact that PAE is used preoperatively in patients with uterine leiomyomas to reduce hemorrhage during surgery, it can also be used as an individual therapy to cease vaginal bleeding in elected patients with this symptomatology, as an alternative to surgical option [ 2 , 6 , 9 ].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations